20132020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 13 Article
  • 1 Comment/Letter to the editor
Filter
Article
2020

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

Poel, D., Gootjes, E. C., Bakkerus, L., Trypsteen, W., Dekker, H., van der Vliet, H. J., van Grieken, N. C. T., Verhoef, C., Buffart, T. E. & Verheul, H. M. W., 2020, In : Cancer Medicine.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Van Der Steen, N., Keller, K., Dekker, H., Porcelli, L., Honeywell, R. J., Van Meerloo, J., Musters, R. J. P., Kathmann, I., Frampton, A. E., Liu, D. S. K., Ruijtenbeek, R., Rolfo, C., Pauwels, P., Giovannetti, E. & Peters, G. J., 1 Jan 2020, In : Journal of Cellular Physiology. 235, 11, 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression

Gonzalez, M. L., Oosterhoff, D., Lindenberg, J. J., Milenova, I., Lougheed, S. M., Martianez, T., Dekker, H., Quixabeira, D. C. A., Hangalapura, B., Joore, J., Piersma, S. R., Cervera-Carrascon, V., Santos, J. M., Scheper, R. J., Verheul, H. M. W., Jimenez, C. R., Van De Ven, R., Hemminki, A., Van Beusechem, V. W. & De Gruijl, T. D., 1 Jan 2019, In : OncoImmunology. 8, 10

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line

van der Steen, N., Leonetti, A., Keller, K., Dekker, H., Funel, N., Lardon, F., Ruijtenbeek, R., Tiseo, M., Rolfo, C., Pauwels, P., Peters, G. J. & Giovannetti, E., 2019, In : Biochemical Pharmacology. 166, p. 128-138

Research output: Contribution to journalArticleAcademicpeer-review

2018

Enhanced Dendritic Cell Development Through Long-Term Proteasome Inhibition

van de Ven, R., Verbrugge, S. E., Al, M., Dekker, H., Verheul, HMW., Anderl, J. L., Chan, E. T., Dijkmans, BAC., Lems, WF., Scheper, RJ., Jansen, G. & de Gruijl, TD., 18 Jan 2018, In : Journal of Molecular and Clinical Medicine. 1, 1, p. 37-46 10 p., DOI: 10.31083/j.jmcm.2018.01.005.

Research output: Contribution to journalArticleAcademicpeer-review

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab

Walraven, M., Homs, M. Y. V., van der Veldt, A. A. M., Dekker, H., Koldenhof, J., Honeywell, R., Barendrecht, A., Sebastian, S. A. E., Parr, N., Koekman, A. C., Voest, E. E., Roest, M., Korporaal, S. J. A. & Verheul, H. M. W., 2018, In : Angiogenesis. 21, 2, p. 325-334

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2016

Sunitinib activates Axl signaling in renal cell cancer

van der Mijn, J. C., Broxterman, H. J., Knol, J. C., Piersma, S. R., De Haas, R. R., Dekker, H., Pham, T. V., Van Beusechem, V. W., Halmos, B., Mier, J. W., Jimenez, C. R. & Verheul, H. M. W., 15 Jun 2016, In : International Journal of Cancer. 138, 12, p. 3002-3010

Research output: Contribution to journalArticleAcademicpeer-review